Michelle Cameron

Associate Professor

  • 1332 Citations
  • 18 h-Index
1989 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1989 2019

Filter
Review article
2019

Approaches to Remyelination Therapies in Multiple Sclerosis

Wooliscroft, L., Silbermann, E., Cameron, M. & Bourdette, D., Jul 1 2019, In : Current Treatment Options in Neurology. 21, 7, 34.

Research output: Contribution to journalReview article

Multiple Sclerosis
Oligodendroglia
Myelin Sheath
Clemastine
Clinical Trials

Assessment and Measurement of Spasticity in MS: State of the Evidence

Hugos, C. L. & Cameron, M., Oct 1 2019, In : Current neurology and neuroscience reports. 19, 10, 79.

Research output: Contribution to journalReview article

Multiple Sclerosis
Elasticity Imaging Techniques
Pain Perception
Spasm
Quality of Life
2017
13 Citations (Scopus)

Cannabinoids for Treatment of MS Symptoms: State of the Evidence

Rice, J. & Cameron, M., Aug 1 2017, In : Current Neurology and Neuroscience Reports. 18, 8, 50.

Research output: Contribution to journalReview article

Cannabinoids
Multiple Sclerosis
Cannabis
Dronabinol
Medical Marijuana
2016

Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders

Frederick, M. C. & Cameron, M. H., Mar 1 2016, In : Current Neurology and Neuroscience Reports. 16, 3, p. 26 1 p.

Research output: Contribution to journalReview article

Diffuse Cerebral Sclerosis of Schilder
Multiple Sclerosis
Neuromyelitis Optica
Encephalomyelitis
Demyelinating Diseases
2004
42 Citations (Scopus)

Valproic acid for agitation in dementia.

Lonergan, E. T., Cameron, M. & Luxenberg, J., 2004, In : Cochrane database of systematic reviews (Online). 2

Research output: Contribution to journalReview article

Valproic Acid
Dementia
Physicians
Placebos
Cross-Over Studies